HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Anis, A. Search for Related Content PubMed Articles by Anis, A.

Review: the cost-effectiveness of interventions for HIV/AIDS in Africa varies greatly

Key Words: anti-HIV agents • cost-benefit analysis

The first 150 words of the full text of this article appear below.

Data sources
Studies were identified by searching Medline, Popline, and EconLit (all from 1984–2000). Bibliographies of relevant articles were reviewed and experts in HIV/AIDS research contacted for unpublished studies.

Study selection
Studies were selected if they reported data for Africa, measured both cost and effectiveness, used standard methods for estimating costs and outcomes, included all major cost items, and allowed a generic measure of outcome (either HIV infections prevented or disability adjusted life years [DALYs] gained) to be calculated. Studies were excluded if the regimen was now out of date, drug prices had changed substantially, or the effectiveness of the intervention had been estimated before the results of clinical trials. Interventions not covered by the initial study selection criteria were included if some cost and effectiveness data existed or the drug costs were available.

Data extraction
Data were extracted on year and country of the study, details of the intervention, year of prices, discount rate, costs . . . [Full text of this article]

Aslam Anis, PhD

University of British Columbia
Vancouver, British Columbia, Canada